Procter and Gamble Co. (PG) has a June fiscal year-end.

Procter and Gamble Co. (PG) has a June fiscal year-end. On June 30, 2006, analysts expected the company to pay $1.41 dividends per share in fiscal year 2007. The company’s market beta is estimated to be 0.7. Assume that the risk-free rate is 4.6% and the market premium is 5%. During fiscal year 2006, the company’s sales growth was 20.2%. However, analysis reveals that P&G’s fiscal 2006 sales include eight months of sales from Gillette after its acquisition by P&G during 2006. Footnotes report pro forma sales that show what the income statement would have reported had Gillette’s full-year sales been included in both 2005 and 2006?specifically, P&G’s sales growth would have been 4.4%.

(a) Estimate P&G’s cost of equity capital using the CAPM model.

(b) Using your rounded answer from (a), estimate P&G’s intrinsic value using the DDM model assuming that dividends per share are projected at $1.41 per share after 2007. (Hint: Apply the DDM model with constant perpetuity.)

(c) Discuss the appropriateness of the estimate computed in part (b) in light of its assumption for no future dividend growth. The DDM model with a constant perpetuity would correctly estimate P&G’s intrinsic value The DDM model with a constant perpetuity would likely underestimate P&G’s intrinsic value The DDM model with a constant perpetuity would likely overestimate P&G’s intrinsic value

(d) If we use the Gordon growth DDM to estimate stock value per share, which sales growth rate should we use (20.2% or 4.4%)? Explain.

i. The 20.2% rate is appropriate.

ii.The 4.4% rate would underestimate the growth rate because the 2006 sales does not include sales from Gillette.

iii.The 4.4% rate is appropriate.

iv.The 20.2% rate would overestimate the growth rate because the 2005 sales number does not include sales from Gillette.

(e) On June 30, 2006, the stock of P&G was priced at $55.60 per share. Infer the market expectation about the future growth rate of P&Gs dividend using the DDM model with an increasing perpetuity and the rounded cost of equity capital computed in (a).